Código QR

Suplatast tosilate reduces peripheral blood eosinophil levels in patients with eosinophilia: A real-world retrospective study

Introduction: Eosinophilia is a rare disease characterized by an increase in eosinophils. Suplatast tosilate is a selective Th2 cytokine inhibitor that can reduce eosinophils. There is currently a lack of clinical studies of suplatast tosilate in the treatment of eosinophilia. Research objective: To...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lu Lyu, Yali Cheng, Jing Zhang, Zhouxian Pan, Rui Tang, Jinlyu Sun, Christopher Chang
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2024-09-01
Colección:Allergy Medicine
Materias:
Acceso en línea:http://www.sciencedirect.com/science/article/pii/S2949913524000041
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!